Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial

Michael Koren, Kayvon Modjarrad, Rafael De La Barrera et al.|The Lancet Infectious Diseases|2023

Cited by 23